seed
Stage
1
Investors
About
Cephagenix develops new treatments specifically targeting migraine by identifying and advancing effective therapeutic options.
Explore Cephagenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.